The University of Chicago Header Logo

Katharine Yao

Concepts (281)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
90
2025
3029
15.510
Why?
Mastectomy
50
2025
254
14.530
Why?
Carcinoma, Ductal, Breast
22
2022
160
7.260
Why?
Carcinoma, Lobular
18
2019
81
5.930
Why?
Mastectomy, Segmental
18
2023
101
4.030
Why?
Surgeons
11
2023
253
3.760
Why?
Time-to-Treatment
6
2025
126
3.480
Why?
Mammaplasty
10
2023
116
3.030
Why?
Cancer Care Facilities
5
2024
31
3.000
Why?
Neoadjuvant Therapy
10
2025
396
2.950
Why?
Quality Indicators, Health Care
6
2024
150
2.860
Why?
Prophylactic Mastectomy
8
2020
13
2.840
Why?
Neoplasm Staging
26
2025
2022
2.650
Why?
Carcinoma, Intraductal, Noninfiltrating
7
2022
117
2.310
Why?
Female
93
2025
47186
2.000
Why?
Lymph Node Excision
10
2021
222
1.970
Why?
Receptors, Estrogen
10
2022
395
1.930
Why?
Middle Aged
67
2025
26555
1.930
Why?
Surgical Oncology
4
2020
28
1.910
Why?
Prognosis
26
2024
3825
1.900
Why?
Sentinel Lymph Node Biopsy
12
2021
80
1.880
Why?
Radiation Oncology
3
2021
122
1.870
Why?
Practice Guidelines as Topic
8
2025
1063
1.800
Why?
Accreditation
3
2019
61
1.760
Why?
Databases, Factual
18
2018
882
1.760
Why?
Aged
53
2025
19574
1.680
Why?
Aged, 80 and over
34
2023
6847
1.560
Why?
Guideline Adherence
4
2018
234
1.550
Why?
Humans
103
2025
91074
1.540
Why?
Follow-Up Studies
21
2020
3716
1.530
Why?
Neoplasm Recurrence, Local
9
2020
1374
1.520
Why?
Chemotherapy, Adjuvant
8
2019
478
1.440
Why?
Radiotherapy, Adjuvant
9
2021
291
1.440
Why?
Unilateral Breast Neoplasms
4
2020
5
1.380
Why?
Patient Reported Outcome Measures
5
2024
210
1.360
Why?
Mastectomy, Subcutaneous
2
2022
8
1.340
Why?
Adult
48
2025
27147
1.340
Why?
Nipples
6
2022
37
1.310
Why?
United States
29
2024
7188
1.210
Why?
Thoracic Wall
2
2018
24
1.200
Why?
Receptor, ErbB-2
5
2019
255
1.180
Why?
Lymph Nodes
4
2018
554
1.150
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2019
2550
1.140
Why?
Practice Patterns, Physicians'
5
2020
608
1.100
Why?
Breast Diseases
2
2022
101
1.090
Why?
Decision Support Techniques
2
2019
171
1.060
Why?
Neoplasm Invasiveness
9
2020
570
1.060
Why?
Ergonomics
3
2022
23
1.050
Why?
Breast Neoplasms, Male
2
2023
31
1.020
Why?
Combined Modality Therapy
8
2021
1713
1.020
Why?
Decision Making
4
2019
675
1.000
Why?
Breast
6
2021
289
0.980
Why?
Neoplasms, Second Primary
3
2017
241
0.960
Why?
Axilla
11
2021
104
0.960
Why?
Biomarkers, Tumor
5
2019
1559
0.950
Why?
Receptors, Progesterone
6
2019
177
0.950
Why?
Survival Rate
12
2018
1898
0.920
Why?
Retrospective Studies
24
2024
9400
0.910
Why?
Surveys and Questionnaires
8
2023
2682
0.890
Why?
Attitude of Health Personnel
4
2023
652
0.860
Why?
Qualitative Research
2
2024
318
0.850
Why?
Young Adult
15
2024
6502
0.840
Why?
Carcinoma
2
2017
438
0.830
Why?
Brachytherapy
2
2014
121
0.820
Why?
Patient Satisfaction
5
2024
464
0.790
Why?
Healthcare Disparities
3
2024
432
0.790
Why?
Organ Sparing Treatments
2
2019
47
0.780
Why?
Medical Overuse
2
2019
36
0.770
Why?
Neoplasm Grading
10
2018
376
0.740
Why?
Quality of Health Care
3
2018
388
0.710
Why?
Oncologists
1
2021
38
0.710
Why?
Lymphatic Metastasis
7
2018
500
0.640
Why?
Age Factors
9
2018
1876
0.640
Why?
Burnout, Professional
1
2021
103
0.640
Why?
Pandemics
7
2025
792
0.640
Why?
Antineoplastic Agents, Hormonal
3
2017
145
0.630
Why?
Stereotaxic Techniques
1
2019
80
0.620
Why?
Prophylactic Surgical Procedures
2
2015
7
0.620
Why?
Patient Selection
6
2019
685
0.610
Why?
Image-Guided Biopsy
1
2019
79
0.600
Why?
Pneumonia, Viral
2
2020
322
0.600
Why?
Coronavirus Infections
2
2020
308
0.600
Why?
Reoperation
5
2015
611
0.590
Why?
Patient Care
1
2019
101
0.580
Why?
Genes, BRCA2
3
2016
161
0.580
Why?
Radiography, Interventional
1
2019
160
0.580
Why?
Genes, BRCA1
3
2016
192
0.570
Why?
Patient Transfer
1
2018
102
0.570
Why?
Consensus
2
2016
374
0.570
Why?
Hospitals, Low-Volume
1
2017
19
0.570
Why?
Hospitals, High-Volume
1
2017
38
0.550
Why?
Patient Acceptance of Health Care
2
2017
267
0.550
Why?
Radiotherapy, Conformal
1
2017
82
0.550
Why?
Logistic Models
7
2017
1216
0.530
Why?
Patient Preference
4
2019
119
0.530
Why?
Adolescent
9
2024
9411
0.520
Why?
Postoperative Complications
7
2016
2348
0.510
Why?
Societies, Medical
2
2019
594
0.500
Why?
Health Knowledge, Attitudes, Practice
2
2019
538
0.490
Why?
Prospective Studies
8
2022
4367
0.470
Why?
Estrogen Receptor alpha
2
2013
148
0.470
Why?
Quality of Life
4
2019
1699
0.450
Why?
Cross-Sectional Studies
5
2024
1753
0.430
Why?
Patient Education as Topic
1
2016
368
0.430
Why?
Elective Surgical Procedures
1
2014
132
0.410
Why?
Receptors, Notch
2
2010
128
0.400
Why?
Length of Stay
3
2015
758
0.400
Why?
Melanoma
2
2009
475
0.390
Why?
Radiotherapy, Intensity-Modulated
1
2013
176
0.390
Why?
Skin Neoplasms
2
2009
603
0.370
Why?
Workload
2
2022
130
0.360
Why?
Operating Rooms
2
2022
125
0.350
Why?
Receptor, Notch1
2
2010
94
0.350
Why?
Patient Readmission
1
2014
367
0.340
Why?
Registries
1
2014
826
0.340
Why?
Gelatin Sponge, Absorbable
1
2008
4
0.320
Why?
Patients
2
2023
104
0.320
Why?
Socioeconomic Factors
3
2016
596
0.300
Why?
Quality Control
2
2019
117
0.290
Why?
Breast Implantation
3
2016
14
0.280
Why?
Proto-Oncogene Proteins
2
2010
667
0.280
Why?
Calcinosis
1
2008
230
0.280
Why?
Incidence
3
2023
1599
0.270
Why?
Pilot Projects
3
2019
887
0.260
Why?
SEER Program
3
2017
202
0.260
Why?
Risk Factors
6
2019
5608
0.260
Why?
Multivariate Analysis
4
2018
982
0.260
Why?
Randomized Controlled Trials as Topic
3
2017
863
0.250
Why?
Health Care Surveys
2
2018
280
0.240
Why?
Risk Assessment
4
2020
2345
0.240
Why?
Proportional Hazards Models
3
2017
852
0.240
Why?
Magnetic Resonance Imaging
1
2017
3500
0.240
Why?
Referral and Consultation
2
2019
352
0.230
Why?
Appointments and Schedules
1
2024
55
0.220
Why?
Male
9
2024
43249
0.220
Why?
Biopsy
3
2014
1196
0.220
Why?
Self Concept
1
2023
135
0.210
Why?
Time Factors
5
2016
5378
0.210
Why?
Radiotherapy Dosage
2
2014
468
0.200
Why?
Cohort Studies
4
2018
2904
0.180
Why?
Gene Expression Profiling
2
2019
1465
0.170
Why?
Betacoronavirus
2
2020
264
0.170
Why?
Mammography
2
2017
470
0.170
Why?
Personnel Selection
1
2020
62
0.170
Why?
Health Resources
1
2020
81
0.160
Why?
Minimally Invasive Surgical Procedures
2
2018
259
0.160
Why?
Body Image
1
2019
80
0.160
Why?
Longitudinal Studies
2
2020
1093
0.160
Why?
Specialties, Surgical
1
2020
70
0.160
Why?
Fear
1
2019
80
0.160
Why?
Triage
1
2020
120
0.160
Why?
User-Computer Interface
1
2020
187
0.160
Why?
Interviews as Topic
1
2020
348
0.160
Why?
Treatment Outcome
5
2018
8436
0.160
Why?
Breast Implants
2
2016
27
0.160
Why?
Uterine Cervical Neoplasms
1
2022
301
0.160
Why?
Fellowships and Scholarships
1
2020
130
0.150
Why?
Anxiety
1
2021
316
0.150
Why?
Neoplasm Micrometastasis
1
2018
6
0.150
Why?
Video Recording
1
2019
204
0.150
Why?
Databases as Topic
1
2018
94
0.150
Why?
Emotions
1
2021
359
0.140
Why?
Patient Participation
1
2019
227
0.140
Why?
Patient Compliance
1
2018
231
0.140
Why?
Choice Behavior
1
2018
162
0.140
Why?
Telemedicine
1
2020
200
0.140
Why?
Heterozygote
2
2016
374
0.140
Why?
Odds Ratio
1
2018
681
0.140
Why?
Sleep
1
2021
458
0.130
Why?
Ultrasonography, Mammary
1
2017
83
0.130
Why?
Disease Management
1
2018
336
0.130
Why?
Surgical Wound Infection
2
2015
205
0.130
Why?
Radiotherapy Planning, Computer-Assisted
1
2017
188
0.130
Why?
Esthetics
1
2016
45
0.130
Why?
Watchful Waiting
1
2016
68
0.130
Why?
Molecular Typing
1
2015
17
0.130
Why?
Illinois
1
2017
499
0.130
Why?
Comprehension
1
2016
81
0.130
Why?
Europe
1
2016
329
0.120
Why?
Pharyngectomy
1
2015
8
0.120
Why?
Neoplasms
2
2022
3053
0.120
Why?
Population Surveillance
1
2016
209
0.120
Why?
Remission Induction
1
2017
756
0.120
Why?
Immunohistochemistry
2
2010
1806
0.120
Why?
Physicians
2
2019
691
0.120
Why?
Counseling
1
2016
169
0.120
Why?
Carcinoma in Situ
1
2015
53
0.120
Why?
Selection Bias
1
2014
36
0.120
Why?
Linear Models
1
2015
426
0.110
Why?
Neoplasm Metastasis
1
2018
1066
0.110
Why?
Case-Control Studies
2
2018
1877
0.110
Why?
Chemoradiotherapy
1
2017
318
0.110
Why?
Colorectal Neoplasms
1
2022
977
0.110
Why?
Adipokines
1
2013
17
0.110
Why?
Cost-Benefit Analysis
1
2016
481
0.110
Why?
Receptor, Notch4
2
2010
5
0.110
Why?
Insurance, Health
1
2014
164
0.110
Why?
Oropharyngeal Neoplasms
1
2015
132
0.110
Why?
Kaplan-Meier Estimate
1
2015
854
0.110
Why?
Fatty Acids
1
2013
141
0.100
Why?
Surgical Flaps
1
2015
254
0.100
Why?
Robotic Surgical Procedures
1
2018
327
0.100
Why?
Venous Thromboembolism
1
2015
162
0.100
Why?
Adipose Tissue
1
2013
263
0.090
Why?
Models, Biological
1
2018
1771
0.090
Why?
Reproducibility of Results
1
2017
2785
0.090
Why?
Health Services Accessibility
1
2014
439
0.090
Why?
Serrate-Jagged Proteins
1
2010
13
0.090
Why?
Jagged-1 Protein
1
2010
13
0.090
Why?
Head and Neck Neoplasms
1
2017
1087
0.090
Why?
Gene Expression Regulation, Neoplastic
1
2015
1295
0.080
Why?
Calcium-Binding Proteins
1
2010
121
0.080
Why?
Lung Neoplasms
1
2022
2380
0.080
Why?
Intercellular Signaling Peptides and Proteins
1
2010
183
0.080
Why?
False Positive Reactions
1
2008
222
0.080
Why?
Receptor Cross-Talk
1
2008
33
0.080
Why?
Interferon-alpha
1
2009
214
0.080
Why?
Hemostatics
1
2008
58
0.080
Why?
Quality Improvement
2
2022
460
0.070
Why?
Neoplastic Cells, Circulating
1
2008
70
0.070
Why?
Early Detection of Cancer
2
2022
427
0.070
Why?
Carcinoma, Squamous Cell
1
2015
1095
0.070
Why?
Biopsy, Needle
1
2008
233
0.070
Why?
Chi-Square Distribution
1
2008
360
0.070
Why?
Hyperplasia
1
2008
153
0.070
Why?
Immunologic Factors
1
2009
172
0.070
Why?
Cancer Vaccines
1
2009
164
0.070
Why?
Drug Delivery Systems
1
2008
181
0.070
Why?
Obesity
1
2013
989
0.070
Why?
Analysis of Variance
1
2008
897
0.070
Why?
RNA, Messenger
1
2012
2033
0.070
Why?
Disease-Free Survival
2
2011
1169
0.060
Why?
Sensitivity and Specificity
1
2008
2020
0.060
Why?
Membrane Proteins
1
2010
1237
0.050
Why?
Predictive Value of Tests
1
2008
1750
0.050
Why?
Immunoenzyme Techniques
2
2013
303
0.050
Why?
Mutation
1
2014
4203
0.050
Why?
Organizational Innovation
1
2020
43
0.040
Why?
Tumor Cells, Cultured
2
2013
1049
0.040
Why?
Genetic Testing
1
2023
544
0.040
Why?
Program Evaluation
1
2020
313
0.040
Why?
Fees and Charges
1
2018
14
0.040
Why?
Hospital Charges
1
2018
29
0.040
Why?
Sentinel Lymph Node
1
2018
21
0.040
Why?
Mass Screening
1
2022
646
0.040
Why?
Propensity Score
1
2018
156
0.040
Why?
Area Under Curve
1
2018
338
0.030
Why?
Urologic Surgical Procedures
1
2018
150
0.030
Why?
Postoperative Care
1
2017
235
0.030
Why?
Tumor Burden
1
2017
316
0.030
Why?
Chicago
1
2020
1452
0.030
Why?
ROC Curve
1
2018
785
0.030
Why?
Cell Proliferation
2
2013
1695
0.030
Why?
Prostatectomy
1
2018
476
0.030
Why?
Self Report
1
2016
300
0.030
Why?
Prosthesis Failure
1
2015
120
0.030
Why?
Communication
1
2018
462
0.030
Why?
Blood Transfusion
1
2015
170
0.030
Why?
Lipase
1
2013
21
0.030
Why?
Serpins
1
2013
32
0.030
Why?
Transplantation, Autologous
1
2015
351
0.030
Why?
Nerve Growth Factors
1
2013
63
0.030
Why?
Risk
1
2015
657
0.030
Why?
Leptin
1
2013
103
0.030
Why?
Physician-Patient Relations
1
2018
627
0.030
Why?
Eye Proteins
1
2013
129
0.030
Why?
Microarray Analysis
1
2012
95
0.030
Why?
Ki-67 Antigen
1
2012
67
0.030
Why?
Contraindications
1
2012
70
0.020
Why?
In Situ Hybridization, Fluorescence
1
2012
355
0.020
Why?
Comorbidity
1
2015
963
0.020
Why?
Sepsis
1
2015
330
0.020
Why?
Body Mass Index
1
2013
784
0.020
Why?
Neoplasms, Hormone-Dependent
1
2008
36
0.020
Why?
Estradiol
1
2008
250
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
492
0.020
Why?
RNA, Small Interfering
1
2008
557
0.020
Why?
Mice, Nude
1
2008
821
0.020
Why?
Mice, Inbred BALB C
1
2008
1102
0.020
Why?
Mice
1
2008
11993
0.010
Why?
Animals
1
2008
27783
0.000
Why?
Yao's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (281)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_